Virtus Investment Advisers »

Eliem Therapeutics shares owned by Virtus Investment Advisers

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Virtus Investment Advisers from 13F filings

Historical chart of Virtus Investment Advisers investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Virtus Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Virtus Investment Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $373k 29k 13.04

More positions owned by Virtus Investment Advisers

Micron Technology (MU)
Datadog Cl A Com (DDOG)
Marvell Technology (MRVL)
Incyte Corporation (INCY)
Applied Materials (AMAT)
Advanced Micro Devices (AMD)
Amgen (AMGN)
Devon Energy Corporation (DVN)
Lam Research Corp Com New (LRCX)
Alnylam Pharmaceuticals (ALNY)
Gilead Sciences (GILD)
Western Digital (WDC)
Kla Corp Com New (KLAC)
Corning Incorporated (GLW)
Regeneron Pharmaceuticals (REGN)

View all positions for Virtus Investment Advisers

Top funds holding Eliem Therapeutics

RA Capital Management
FMR
UBS Group
Braidwell
Adage Capital Partners GP
BlackRock
Cormorant Asset Management
Frontier Capital Management
T. Rowe Price Associates
Vanguard Capital Management
Woodline Partners
Citadel Advisors
Redmile Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors

View all funds holding Eliem Therapeutics